These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 188956)
1. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia. Shattil SJ; Bennett JS; Colman RW; Cooper RA J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956 [TBL] [Abstract][Full Text] [Related]
2. Platelet function in hyperbetalipoproteinemia. Colman RW Thromb Haemost; 1978 Apr; 39(2):284-93. PubMed ID: 580982 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol:phospholipid ratio is elevated in platelet plasma membrane in patients with hypertension. Benjamin N; Robinson BF; Graham JG; Wilson RB J Hum Hypertens; 1990 Jun; 4(3):273-6. PubMed ID: 2362260 [TBL] [Abstract][Full Text] [Related]
4. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma]. Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612 [TBL] [Abstract][Full Text] [Related]
5. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702 [TBL] [Abstract][Full Text] [Related]
6. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. Cooper RA J Supramol Struct; 1978; 8(4):413-30. PubMed ID: 723275 [TBL] [Abstract][Full Text] [Related]
7. Platelet hypersensitivity induced by cholesterol incorporation. Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069 [TBL] [Abstract][Full Text] [Related]
8. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
9. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation. Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252 [TBL] [Abstract][Full Text] [Related]
10. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. Bilheimer DW; Stone NJ; Grundy SM J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811 [TBL] [Abstract][Full Text] [Related]
11. Halofenate: a potent inhibitor of normal and hypersensitive platelets. Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Schrör K; Löbel P; Steinhagen-Thiessen E Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819 [TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia. Aviram M; Brook JG Isr J Med Sci; 1985 Nov; 21(11):898-904. PubMed ID: 4077486 [TBL] [Abstract][Full Text] [Related]
15. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981 [TBL] [Abstract][Full Text] [Related]
16. Membrane microviscosity and human platelet function. Shattil SJ; Cooper RA Biochemistry; 1976 Nov; 15(22):4832-7. PubMed ID: 990246 [TBL] [Abstract][Full Text] [Related]
17. Interactions between lipoproteins and platelet membranes in obesity. Raffaelli F; Nanetti L; D'Angelo M; Montecchiani G; Alidori A; Montesi L; Faloia E; Vignini A; Mazzanti L Obesity (Silver Spring); 2009 Jul; 17(7):1375-80. PubMed ID: 19197263 [TBL] [Abstract][Full Text] [Related]
18. Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia. Tretjakovs P; Kalnins U; Dabina I; Dinne I; Erglis A; Kumsars I; Jurka A Med Sci Monit; 2000; 6(3):507-11. PubMed ID: 11208362 [TBL] [Abstract][Full Text] [Related]
19. Influence of cholesterol-lowering on plasma membrane lipids and function. Lijnen P; Echevaría-Vázquez D; Petrov V Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244 [TBL] [Abstract][Full Text] [Related]
20. [Plasma lipoproteins and aortic collagen fractions in rabbits with different degrees of atherosclerosis]. Gerasimova EN; Torkhovskaia TI; Perova NV; Bazanova EA Vopr Med Khim; 1979; 25(4):471-80. PubMed ID: 224599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]